Melatonin (Extended Release).

Tryptophan is the starting amino acid of the pineal route, moving through 5-HTP and serotonin before the final two enzyme steps produce melatonin. It feeds endogenous production while a melatonin dose acts at the receptor end.

5-HTP sits one enzyme step from serotonin, which is then acetylated and methylated into melatonin. It bypasses the rate-limiting hydroxylation of tryptophan, feeding the same route more directly.

Pyridoxal-5-phosphate is the cofactor for aromatic amino acid decarboxylase, the enzyme converting 5-HTP into serotonin upstream of melatonin. Low B6 slows that precursor step.

P5P is the coenzyme form of B6 used directly by aromatic amino acid decarboxylase on the 5-HTP step. It needs no liver conversion first.

The last step of melatonin synthesis is a methylation of N-acetylserotonin by ASMT, and SAM is the methyl donor for it. Methyl group supply is part of endogenous melatonin output.

Glycine acts at the NMDA receptor glycine site and increases peripheral blood flow, lowering core body temperature. Melatonin signals the same temperature shift through its own MT1 and MT2 receptors.

Most dietary tryptophan is pulled down the kynurenine route toward NAD synthesis rather than toward serotonin. Preformed niacin lowers that demand, leaving more tryptophan for the serotonin and melatonin branch.

Caffeine blocks adenosine receptors and works against the sleep pressure melatonin signals. Both are cleared by CYP1A2, so caffeine competes for that enzyme and can raise melatonin blood levels while opposing its effect.

St. John's Wort induces CYP1A2 and CYP3A4, the enzymes that clear melatonin, so co-use can cut circulating melatonin exposure from the same dose.

Montmorency cherry contains measurable melatonin along with tryptophan. Taken with a melatonin dose the intake is additive rather than a separate mechanism.

Magnesium acts at NMDA and GABA-A sites, so pairing it with melatonin combines a receptor-level calming input with melatonin's circadian timing signal. The two work on different levers rather than the same one, which is why they appear together in evening formulations. Anyone already using a sedating medicine should count the combined sedative load rather than each product separately.

L-theanine raises alpha-band cortical activity and dampens sympathetic arousal without shifting clock timing. Melatonin does the opposite, signalling biological night without directly reducing arousal. Combining them addresses two separate reasons a person lies awake, and an extended-release melatonin holds its signal across the night while theanine acts early.

Oral GABA crosses the blood brain barrier poorly, so its effects are usually attributed to peripheral and enteric receptors rather than direct central action. Where a sedating effect does occur it stacks with melatonin's. The additive sedation is the practical point, not a shared mechanism.

Valerian constituents modulate GABA-A receptors and valerian is one of the most common co-ingredients in evening blends with melatonin. The sedative inputs add. With an extended-release melatonin the release curve outlasts valerian's shorter action, so the two cover different parts of the night.

Passionflower flavonoids including chrysin have affinity for benzodiazepine binding sites on GABA-A receptors. Layered onto melatonin the sedative effect is additive rather than mechanistically linked. Formulators pair them because the subjective effects differ, one calming and one timing.

Lemon balm rosmarinic acid inhibits GABA transaminase, which raises local GABA availability. That is a different route to evening calm than melatonin's MT1 and MT2 receptor signalling. The combined sedative load is what a user notices.

Chamomile's apigenin binds benzodiazepine sites, which is the pharmacological basis behind its long use as an evening tea. Alongside melatonin the effects add. This is a traditional pairing with a plausible receptor rationale, not a tested combination.

Apigenin is the chamomile constituent that carries the benzodiazepine-site affinity, and it is now sold isolated for evening use. Its action is on arousal, melatonin's is on timing. Sedative effects add and should be counted together.

Honokiol and magnolol are positive modulators at GABA-A receptors, and magnolia bark also blunts evening cortisol in some reports. Melatonin contributes no GABAergic activity of its own. The pairing is additive sedation across two systems.

Ashwagandha acts on the hypothalamic pituitary adrenal axis and lowers evening cortisol in several human reports. Cortisol and melatonin run in opposite phase across the night, so reducing one while supplying the other pushes the same direction. Cortisol is a marker here, not an outcome.

A 2026 review examined vitamin D, myo-inositol and melatonin as a combined redox and endocrine strategy in women with irregular cycles. Myo-inositol acts as an insulin second messenger while melatonin contributes circadian and antioxidant signalling. A review proposing a combination is a hypothesis about it, not a measurement of it.

The same 2026 review grouped vitamin D with melatonin on the grounds that both feed into redox balance and endocrine signalling. Vitamin D receptor activity and melatonin receptor activity are separate pathways that the authors argue converge. No combination trial is cited for the pairing.

Zinc participates broadly in enzymes of amino acid and indole handling that sit upstream of melatonin synthesis. For supplemental extended-release melatonin the endogenous pathway is bypassed, so this matters more for the body's own production than for the dose taken. Stated as background biochemistry rather than a supplementation effect.

Tetrahydrobiopterin regeneration and one-carbon flux support tryptophan hydroxylase activity, and serotonin is the direct precursor the pineal acetylates and methylates into melatonin. Folate status therefore sits upstream of endogenous melatonin production. Taking melatonin itself does not depend on folate; the body's own synthesis does.

The last step of melatonin synthesis is an S-adenosylmethionine-dependent O-methylation of N-acetylserotonin, and B12 keeps the methionine cycle turning that regenerates SAM. Poor B12 status constrains methyl group supply generally. This is upstream biochemistry, separate from any effect of a swallowed dose.

Berberine activates AMPK and lowers fasting glucose markers, and melatonin supplementation has been examined for its effect on the same markers in adults with high blood sugar. Taken together the glucose-lowering inputs may add. Anyone monitoring blood glucose should watch it rather than assume the effects are independent.

Most green tea extracts carry residual caffeine, an adenosine receptor antagonist that opposes sleep pressure directly. Melatonin does not block that antagonism. Evening dosing of a caffeinated extract works against an extended-release melatonin taken at the same time.

Panax ginseng is generally taken for daytime alertness and is reported to be activating in a subset of users. That runs against the direction melatonin is taken for. Separating them by time of day is the ordinary formulation practice.

Rhodiola is commonly reported as activating and is dosed in the morning for that reason. Pairing it with an evening melatonin puts two opposing signals into the same day. This is a timing conflict rather than a chemical interaction.

NAC supplies cysteine for glutathione synthesis while melatonin scavenges radicals directly and is itself oxidised in the process. The two support different arms of the antioxidant network. Oxidative stress readouts are markers, not clinical outcomes.

Alpha-lipoic acid cycles between dithiol and disulfide states and helps regenerate other antioxidants, while melatonin acts as a terminal scavenger that is consumed. Both are amphipathic enough to reach aqueous and lipid compartments. The claim here is about redox markers, not a health endpoint.

Coenzyme Q10 carries electrons within the inner mitochondrial membrane and limits lipid peroxidation there, and melatonin concentrates in mitochondria as well. The two overlap in compartment while acting by different chemistry. Reported effects are on oxidative markers.